Guru Ownership Trend
Guru Analysis for Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $19.89 M.
Top institutional holders include Stanley Druckenmiller and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $15.21 M net inflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 133.3%. Conversely, Steven Cohen reduced exposure by 76.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Olema Pharmaceuticals, Inc. (OLMA)
Major holders include Stanley Druckenmiller ($14.71 M), Ken Fisher ($4.47 M), Cliff Asness ($1.34 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.45 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $15.21 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited OLMA. The total reported sell value was $4.16 M.
Yes, 2 managers opened new positions in OLMA, and 2 increased their existing holdings. The total reported buy value was $19.37 M.